| Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance W Wu, JL Klockow, M Zhang, F Lafortune, E Chang, L Jin, Y Wu, ... Pharmacological research 171, 105780, 2021 | 279 | 2021 |
| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Nature communications 10 (1), 4016, 2019 | 257 | 2019 |
| CD70, a novel target of CAR T-cell therapy for gliomas L Jin, H Ge, Y Long, C Yang, Y Chang, L Mu, EJ Sayour, G De Leon, ... Neuro-oncology 20 (1), 55-65, 2018 | 163 | 2018 |
| Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang, W Zhang, ... Cancer research 80 (3), 499-509, 2020 | 86 | 2020 |
| The IDH1 mutation-induced oncometabolite, 2-hydroxyglutarate, may affect DNA methylation and expression of PD-L1 in gliomas L Mu, Y Long, C Yang, L Jin, H Tao, H Ge, YE Chang, A Karachi, ... Frontiers in molecular neuroscience 11, 82, 2018 | 78 | 2018 |
| Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM H Ge, L Mu, L Jin, C Yang, Y Chang, Y Long, G DeLeon, L Deleyrolle, ... International Journal of Cancer 141 (7), 1434-1444, 2017 | 78 | 2017 |
| CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma YP Park, L Jin, KB Bennett, D Wang, KM Fredenburg, JE Tseng, LJ Chang, ... Oral Oncology 78, 145-150, 2018 | 49 | 2018 |
| CD4+ and perivascular Foxp3+ T cells in glioma correlate with angiogenesis and tumor progression L Mu, C Yang, Q Gao, Y Long, H Ge, G DeLeon, L Jin, Y Chang, ... Frontiers in immunology 8, 1451, 2017 | 49 | 2017 |
| CAR T cell locomotion in solid tumor microenvironment DT Nguyen, E Ogando-Rivas, R Liu, T Wang, J Rubin, L Jin, H Tao, ... Cells 11 (12), 1974, 2022 | 21 | 2022 |
| Optimizing T cell-based therapy for glioblastoma A Karachi, F Dastmalchi, S Nazarian, J Huang, EJ Sayour, L Jin, C Yang, ... Frontiers in immunology 12, 705580, 2021 | 10 | 2021 |
| Multimodal in vivo tracking of chimeric antigen receptor T cells in preclinical glioblastoma models WE Wu, E Chang, L Jin, S Liu, CH Huang, R Kamal, T Liang, NM Aissaoui, ... Investigative Radiology 58 (6), 388-395, 2023 | 7 | 2023 |
| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat. Commun. 10, 4016 L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Molecular Therapy: Methods & Clinical Development, 2019 | 7 | 2019 |
| Three-dimensional bioconjugated liquid-like solid (LLS) enhance characterization of solid tumor-Chimeric antigen receptor T cell interactions DT Nguyen, R Liu, E Ogando-Rivas, A Pepe, D Pedro, S Qdasait, ... bioRxiv, 2023 | 3 | 2023 |
| CD70 as a critical mediator of tumor progression and immunosuppression in gliomas. C Yang, H Ge, L Jin, QJ Wang, JC Yang, Y Long, Y Chang, J Drake, L Mu, ... Journal of clinical oncology 35 (7_suppl), 18-18, 2017 | 2 | 2017 |
| Bioconjugated liquid-like solid enhances characterization of solid tumor-chimeric antigen receptor T cell interactions DT Nguyen, R Liu, E Ogando-Rivas, A Pepe, D Pedro, S Qdaisat, ... Acta Biomaterialia 172, 466-479, 2023 | 1 | 2023 |
| CD70-A NOVEL TARGET OF CAR-T-CELL THERAPY FOR GLIOMAS L Jin, H Ge, C Yang, Y Long, Y Chang, L Mu, E Sayour, G De Leon, ... NEURO-ONCOLOGY 18, 91-92, 2016 | 1 | 2016 |
| Blocking Immune Checkpoint—LAIR1: Disrupting the LAIR1—FXIII-A—Collagen Immunosuppressive Circuit for Enhanced Antitumor Therapeutics J Huang, H Tao, D Chen, C Yang, D Nguyen, R Liu, T Liu, A Chakraborty, ... | | 2024 |
| CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia JA Ligon, P Castillo, X Ma, L Jin, H Tao, D Nguyen, G Jobin, O Guryanova, ... Transplantation and Cellular Therapy 30 (2), S178-S179, 2024 | | 2024 |
| AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY H Tao, D Chen, C Yang, D Nguyen, A Pepe, D Pedro, L Jin, R Liu, T Liu, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| 269 CAR T cell production expands endogenous T cell repertoire recognizing additional tumor antigen (s) A Hou, L Jin, H Tao, DA Mitchell, J Huang Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
